francesca megiorni
Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Editors
Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
The University of Iowa
Iowa City, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Michigan Medicine, University of Michigan
Ann Arbor, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Campus Bio-Medico University
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Washington
Seattle, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Kindai University
Higashi-osaka, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics
Faculté de Médecine, Aix Marseille Université
Marseille, France
Associate Editor
Cancer Molecular Targets and Therapeutics
Warren Alpert Medical School, Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Exeter
Exeter, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
Wuhan, China
Associate Editor
Cancer Molecular Targets and Therapeutics
European University Cyprus
Engomi, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Birmingham
Birmingham, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wrocław, Poland
Associate Editor
Cancer Molecular Targets and Therapeutics
University of California, Riverside
Riverside, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Department of Chemistry, School of Science, University of Patras
Patras, Greece
Associate Editor
Cancer Molecular Targets and Therapeutics
Newcastle University
Newcastle upon Tyne, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics